Receiving the first dose of the HPV vaccine at age 9, rather than bundling it with the Tdap and meningitis vaccines, appears to increase the likelihood that children will complete the HPV vaccine series.
Data on the course and prognosis of warts in pediatric patients being treated for cancer compared with patients who have completed treatment have been limited.